<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112459358</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112459358</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nutrition Support of Neonatal Patients at Risk for Necrotizing Enterocolitis</article-title>
<subtitle>Response to Fallon et al (2012)</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>van Elburg</surname><given-names>Ruurd M.</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Neu</surname><given-names>Josef</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
</contrib-group>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>37</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>11</lpage>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>With interest, we read the article by Fallon et al<sup><xref ref-type="bibr" rid="bibr1-0148607112459358">1</xref></sup> on nutrition support of neonatal patients at risk for necrotizing enterocolitis (NEC). The incidence of NEC and its attendant mortality and morbidities remain high despite general improvement in neonatal care. Nutrition, either parenteral or enteral, is a key component in both the occurrence and management of NEC. Therefore, we are very pleased with the effort of the authors (reviewing 1335 abstracts) to review the literature on the relation of nutrition with NEC.</p>
<p>Every literature search strategy depends heavily on the selection of keywords and limitations. Although the authors describe their selection for the 5 questions raised, it is unclear what the authors imply by their specification that “pertinent literature within the past 10 years, without restriction to the evidence type.”</p>
<p>In question 4 concerning the role of certain nutrients in the prevention or predisposition of NEC, the authors conclude, based on 1 randomized controlled trial by Poindexter et al,<sup><xref ref-type="bibr" rid="bibr2-0148607112459358">2</xref></sup> that there is strong evidence that glutamine supplementation cannot be recommended for infants at risk for NEC. We strongly disagree with this conclusion for the following reasons. First, the incidence of NEC was not the primary aim of the multicenter trial by Poindexter et al.<sup><xref ref-type="bibr" rid="bibr2-0148607112459358">2</xref></sup> Therefore, it is not justified to use the data as “strong” evidence for this contention. In addition, the quality of the trial was quite poor, as reviewed by us and others<sup><xref ref-type="bibr" rid="bibr3-0148607112459358">3</xref>,<xref ref-type="bibr" rid="bibr4-0148607112459358">4</xref></sup> (eg, the extra parenteral supplementation of glutamine replaced other, in part essential, amino acids in order to have an isonitrogeneous amino acid solution). Second, glutamine was supplemented by the parenteral route, which has very different effects than by the enteral route. By the enteral route, around 70% of glutamine is used in first pass,<sup><xref ref-type="bibr" rid="bibr5-0148607112459358">5</xref></sup> and although none of the trials on enteral glutamine had NEC as the primary outcome, some studies on enteral glutamine supplementation showed positive effects on clinical end points.<sup><xref ref-type="bibr" rid="bibr4-0148607112459358">4</xref>,<xref ref-type="bibr" rid="bibr6-0148607112459358">6</xref><xref ref-type="bibr" rid="bibr7-0148607112459358"/>-<xref ref-type="bibr" rid="bibr8-0148607112459358">8</xref></sup> Third, in studies in cell cultures and animals, favorable effects of enteral supplementation of glutamine were found on the modulation of stress-induced intestinal injury, which plays a role in the susceptibility to develop NEC.<sup><xref ref-type="bibr" rid="bibr9-0148607112459358">9</xref>,<xref ref-type="bibr" rid="bibr10-0148607112459358">10</xref></sup> Fourth, low plasma concentrations of glutamine have been associated with a higher incidence of NEC.<sup><xref ref-type="bibr" rid="bibr11-0148607112459358">11</xref></sup></p>
<p>In conclusion, although enteral glutamine supplementation has not been shown to prevent NEC, there is no strong evidence that enteral glutamine supplementation may not be beneficial for neonatal patients, especially extremely low birth weight and extremely preterm infants.</p>
<sig-block>
<sig>Ruurd M. van Elburg, MD, PhD<break/>
<italic>VU University Medical Center Amsterdam, Amsterdam, Netherlands</italic><break/>
Josef Neu, MD, PhD<break/>
<italic>University of Florida, Gainesville, USA</italic></sig>
</sig-block>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112459358">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fallon</surname><given-names>EM</given-names></name>
<name><surname>Nehra</surname><given-names>D</given-names></name>
<name><surname>Potemkin</surname><given-names>AK</given-names></name>
<etal/>
</person-group>. <article-title>A.S.P.E.N. clinical guidelines: nutrition support for neonatal patients at risk for necrotizing enterocolitis</article-title> <source>JPEN J Parenter Enteral Nutr</source>. <year>2012</year>;<volume>36</volume>:<fpage>506</fpage>-<lpage>523</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112459358">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Poindexter</surname><given-names>BB</given-names></name>
<name><surname>Ehrenkranz</surname><given-names>RA</given-names></name>
<name><surname>Stoll</surname><given-names>BJ</given-names></name>
<etal/>
</person-group>. <article-title>Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants</article-title>. <source>Pediatrics</source>. <year>2004</year>;<volume>113</volume>:<fpage>1209</fpage>-<lpage>1215</lpage>.</citation>
</ref>
<ref id="bibr3-0148607112459358">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Zwol</surname><given-names>A</given-names></name>
<name><surname>Neu</surname><given-names>J</given-names></name>
<name><surname>van Elburg</surname><given-names>RM</given-names></name>
</person-group>. <article-title>Long term effects of neonatal glutamine-enriched nutrition in very low birth weight infants</article-title>. <source>Nutr Rev</source>. <year>2011</year>;<volume>69</volume>:<fpage>2</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112459358">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moe-Byrne</surname><given-names>T</given-names></name>
<name><surname>Wagner</surname><given-names>JVE</given-names></name>
<name><surname>McGuire</surname><given-names>W</given-names></name>
</person-group>. <article-title>Glutamine supplementation to prevent morbidity and mortality in preterm infants</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2012</year>;(<issue>3</issue>):<fpage>CD001457</fpage>.</citation>
</ref>
<ref id="bibr5-0148607112459358">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Schoor</surname><given-names>SR</given-names></name>
<name><surname>Schierbeek</surname><given-names>H</given-names></name>
<name><surname>Bet</surname><given-names>PM</given-names></name>
<etal/>
</person-group>. <article-title>Majority of dietary glutamine is utilized in first pass in preterm infants</article-title>. <source>Pediatr Res</source>. <year>2010</year>;<volume>67</volume>: <fpage>194</fpage>-<lpage>199</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112459358">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neu</surname><given-names>J</given-names></name>
<name><surname>Roig</surname><given-names>JC</given-names></name>
<name><surname>Meetze</surname><given-names>WH</given-names></name>
<etal/>
</person-group>. <article-title>Enteral glutamine supplementation for very low birth weight infants decreases morbidity</article-title>. <source>J Pediatr</source>. <year>1997</year>;<volume>131</volume>: <fpage>691</fpage>-<lpage>699</lpage>.</citation>
</ref>
<ref id="bibr7-0148607112459358">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van den Berg</surname><given-names>A</given-names></name>
<name><surname>van Elburg</surname><given-names>RM</given-names></name>
<name><surname>Westerbeek</surname><given-names>EA</given-names></name>
<name><surname>Twisk</surname><given-names>JW</given-names></name>
<name><surname>Fetter</surname><given-names>WP</given-names></name>
</person-group>. <article-title>Glutamine-enriched enteral nutrition in very low birth weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial</article-title>. <source>Am J Clin Nutr</source>. <year>2005</year>:<volume>81</volume>:<fpage>1397</fpage>-<lpage>1404</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112459358">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sevastiadou</surname><given-names>S</given-names></name>
<name><surname>Malamitsi-Puchner</surname><given-names>A</given-names></name>
<name><surname>Costalos</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>The impact of oral glutamine supplementation on the intestinal permeability and incidence of necrotizing enterocolitis/septicemia in premature neonates</article-title>. <source>J Matern Fetal Neonatal Med</source>. <year>2011</year>;<volume>24</volume>(<issue>10</issue>):<fpage>1294</fpage>-<lpage>1300</lpage>.</citation>
</ref>
<ref id="bibr9-0148607112459358">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neu</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>N</given-names></name>
</person-group>. <article-title>Pathophysiology of glutamine and glutamate metabolism in premature infants</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>. <year>2007</year>;<volume>10</volume>:<fpage>75</fpage>-<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112459358">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>N</given-names></name>
<name><surname>Ma</surname><given-names>L</given-names></name>
<name><surname>Liu</surname><given-names>X</given-names></name>
<etal/>
</person-group>. <article-title>Arginyl-glutamine dipeptide or docosahexaenoic acid attenuates hyperoxia-induced small intestinal injury in neonatal mice</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>2012</year>;<volume>54</volume>:<fpage>499</fpage>-<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr11-0148607112459358">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Becker</surname><given-names>RM</given-names></name>
<name><surname>Wu</surname><given-names>G</given-names></name>
<name><surname>Galanko</surname><given-names>JA</given-names></name>
<etal/>
</person-group>. <article-title>Reduced serum amino acid concentrations in infants with necrotizing enterocolitis</article-title>. <source>J Pediatr</source>. <year>2000</year>;<volume>137</volume>: <fpage>785</fpage>-<lpage>793</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>